Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aker BioMarine, an integrated biotechnology company positioned to create value from krill harvesting and processing and Lipogen, a producer of the functional cognitive ingredient phosphatidylserine (PS), have joined forces to develop a phospholipids formula for cognitive health.
Subscribe to our email newsletter
Aker BioMarine and Lipogen said that the target formula is a matrix of Lipogen PS phosphatidylserine produced from Aker BioMarine’s pure Superba Krill Oil.
Reportedly, Phosphatidylserine (PS) and omega-3 fatty acids are both key components of the brain’s cell membranes. The new ingredient could either be applied together with multivitamins or as a single ingredient targeting brain health.
Lipogen claimed that PS, a natural brain ingredient is a clinically proven nutritional supplement. It is designed to boost cognitive ability in adults whose cognitive function is slowing down due to age-related decline in memory and other cognition areas, as detailed in two qualified, FDA health claims.
Aker BioMarine claimed that Superba Krill Oil, a lipid extract from the crustacean Antarctic Krill (Euphausia superba), is rich in omega-3 phospholipids and the powerful antioxidant astaxanthin. Studies have demonstrated that omega-3 fatty acids from Superba Krill Oil are incorporated more efficiently into cell membranes than triglycerides omega-3s from fish oil.
Matts Johansen, executive vice president of Aker BioMarine, said: “This new ingredient is expected to combine two clinically tested ingredients, Lipogen PS and our pure Superba Krill Oil.”
David Rutenberg, CEO of Lipogen, said: “Lipogen is proud to join forces with Aker BioMarine to develop this ingredient. PS acts synergistically with omega-3 fatty acids to increase cognitive abilities, supporting memory, mood, concentration, stress control and other cognitive functions.”